Which has grown faster, NRC or RXRX?

Over the past five years, RXRX grew revenue faster — NRC at a -0.02% CAGR versus RXRX at 45.50%.

Does NRC or RXRX pay a bigger dividend?

NRC pays a dividend (2.81% yield), while RXRX has no payments in the available dividend history.

Is NRC or RXRX more profitable?

NRC runs the higher net margin — NRC at 4.18% versus RXRX at -945.92%.

How have NRC and RXRX total returns compared?

Over the past 5 years, NRC delivered -10.90% and RXRX delivered -28.56% annualized total return. Past performance doesn't predict future results.

NRC Health (NRC) vs Recursion Pharmaceuticals, Inc. (RXRX)

A side-by-side comparison of NRC Health and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

NRC

NRC Health

$459M

$20.38HealthcareDelayed quote: Oct 2, 2026, 3:39 PM EDT

RXRX

Recursion Pharmaceuticals, Inc.

$2.14B

$4.08HealthcareDelayed quote: Oct 2, 2026, 3:40 PM EDT

Total return — NRC vs RXRX

growth of $100 · dividends reinvested · last 5y

NRC -48.6% (-12.5%/yr)RXRX -77.4% (-25.7%/yr)NRC compounded faster over this window

NRC RXRX

NRC vs RXRX: by the numbers

•RXRX is the larger company ($2.14B vs $459M market cap).
•NRC is profitable (4.18% net margin) while RXRX runs a net loss (-945.92%).
•RXRX grew revenue faster over the past five years (45.50% vs -0.02% CAGR).
•NRC pays a dividend (2.81% yield), while RXRX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	NRC	RXRX
P/E ratio	80.74	N/A
Forward P/E	23.16	N/A
P/S ratio	3.28	39.05
P/B ratio	70.13	2.34
EV / EBITDA	23.37	N/A
FCF yield	4.71%	N/A

Profitability

Metric	NRC	RXRX
Gross margin	56.33%	-61.96%
Operating margin	10.53%	-867.87%
Net margin	4.18%	-945.92%
ROE	89.43%	-56.71%
ROIC	8.75%	-49.78%

Dividends

Metric	NRC	RXRX
Dividend yield	2.81%	N/A
Payout ratio	237.72%	N/A

Growth (annualized)

Metric	NRC	RXRX
Revenue CAGR (5Y)	-0.02%	45.50%
EPS CAGR (5Y)	-18.88%	N/A
FCF CAGR (5Y)	-14.35%	N/A
Total return CAGR (5Y)	-10.90%	-28.56%

Frequently asked

Which has grown faster, NRC or RXRX?: Over the past five years, RXRX grew revenue faster — NRC at a -0.02% CAGR versus RXRX at 45.50%.
Does NRC or RXRX pay a bigger dividend?: NRC pays a dividend (2.81% yield), while RXRX has no payments in the available dividend history.
Is NRC or RXRX more profitable?: NRC runs the higher net margin — NRC at 4.18% versus RXRX at -945.92%.
How have NRC and RXRX total returns compared?: Over the past 5 years, NRC delivered -10.90% and RXRX delivered -28.56% annualized total return. Past performance doesn't predict future results.

Go deeper

Full NRC analysis Full RXRX analysis Interactive comparison tool

Dig into the metrics

NRC Health P/E ratio NRC Health dividend yield NRC Health ROE Recursion Pharmaceuticals ROE NRC Health operating margin Recursion Pharmaceuticals operating margin NRC Health revenue growth Recursion Pharmaceuticals revenue growth NRC Health free cash flow Recursion Pharmaceuticals free cash flow

NRC Health & Recursion Pharmaceuticals appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.